The Importance of a Low Glycemic Diet in Cancer Prevention, Treatment, and Survivorship
Updated: 2 days ago

Nutrition plays an important role in cancer prevention, treatment, and survivorship, yet one area that is often overlooked is the relationship between blood glucose, insulin, and cancer biology. While most people associate insulin with diabetes and blood sugar regulation, insulin also influences cellular growth, metabolism, and hormone activity. When insulin levels remain chronically elevated, particularly in individuals with insulin resistance and excess adipose tissue, several biological pathways associated with cancer development and progression may be affected. Understanding these relationships can help us make more informed nutritional choices that support metabolic health.
Throughout my years of clinical practice in integrative oncology, I have emphasized the importance of individualized nutrition as part of comprehensive cancer care. One strategy I frequently discuss is choosing foods that support healthy blood glucose regulation and insulin sensitivity. A low glycemic dietary pattern may be particularly beneficial for individuals with insulin resistance, metabolic syndrome, type 2 diabetes, or excess visceral adiposity. However, the importance of maintaining healthy metabolic function extends beyond blood sugar management.
Understanding the Relationship Between Insulin and Cancer
When we consume carbohydrates, our digestive system breaks them down into simple sugars, primarily glucose, which enters the bloodstream. In response, the pancreas releases insulin, a hormone that helps transport glucose into cells, where it can be used for energy or stored for future use. However, when cells become less responsive to insulin, a condition known as insulin resistance, the pancreas may compensate by producing increasingly larger amounts of insulin.
This can result in chronically elevated insulin levels, a condition known as hyperinsulinemia.
Insulin is not only responsible for regulating blood glucose, but also participates in cellular growth and survival signaling. Insulin and a related hormone, insulin like growth factor 1 (IGF 1), activate pathways that regulate cellular proliferation, metabolism, and programmed cell death. These pathways are necessary for normal tissue maintenance, but abnormal activation may also contribute to cancer growth and progression. Elevated insulin and IGF 1 signaling have been investigated in relation to several cancers, including breast, colorectal, and endometrial cancers.
One important pathway involves PI3K, AKT, and mTOR, which regulate cellular growth and survival. Many cancers exhibit abnormal activation of these pathways, allowing malignant cells to proliferate and resist normal mechanisms of cell death. Although elevated insulin does not independently cause cancer, chronic hyperinsulinemia may contribute to biological conditions that favor tumor development or progression in certain contexts. This is one reason maintaining healthy insulin sensitivity is an important consideration in cancer prevention and survivorship.
Excess Adipose Tissue and Increased Cancer Risk
Adipose tissue, commonly referred to as body fat, is much more than a storage site for excess calories. It is a metabolically active tissue that produces hormones, inflammatory molecules, and other substances involved in immune regulation and cellular signaling. Excess visceral adipose tissue, which accumulates around internal organs, is particularly associated with insulin resistance, chronic inflammation, and metabolic dysfunction. These changes are among the mechanisms linking excess body fat with increased risk for several cancers.
Excess adipose tissue can increase the production of inflammatory molecules, including interleukin 6 (IL 6) and tumor necrosis factor alpha (TNF alpha), which may influence cellular proliferation and the tissue environment surrounding developing tumors. Adipose tissue also produces hormones called adipokines, including leptin and adiponectin, which influence inflammation and insulin sensitivity. As body fat increases, leptin levels often rise while adiponectin levels decline, potentially contributing to further metabolic dysfunction. These changes illustrate why maintaining a healthy body composition is important for long term health.
Insulin, Estrogen, Progesterone, and Testosterone: The Hormonal Connection
One of the most clinically significant relationships between insulin resistance, excess adipose tissue, and cancer involves sex hormone regulation. Hormones such as estrogen, progesterone, and testosterone play essential roles in normal physiological function, but changes in their production, availability, and signaling can influence certain hormone sensitive cancers. The relationship is complex and differs between men and women, particularly before and after menopause. Understanding these differences is especially relevant for individuals with a history of breast, endometrial, or prostate cancer.
Estrogen and Hormone Sensitive Cancers
Adipose tissue contains an enzyme called aromatase, which converts androgen hormones into estrogens. After menopause, when ovarian estrogen production decreases, adipose tissue becomes an important source of circulating estrogen. Consequently, women with increased adipose tissue may have greater estrogen exposure, which is associated with increased risk of estrogen receptor positive breast cancer and endometrial cancer. Insulin resistance can further influence estrogen availability by reducing production of sex hormone binding globulin (SHBG), a protein that regulates the amount of circulating sex hormones available to tissues.
Progesterone and Endometrial Cancer
Insulin resistance can interfere with normal reproductive hormone regulation, particularly in women with conditions such as polycystic ovary syndrome (PCOS). When ovulation becomes irregular or absent, progesterone production may decrease, resulting in prolonged estrogen exposure without the normal balancing effects of progesterone. This hormonal environment can contribute to endometrial hyperplasia and increase the risk of endometrial cancer. In breast tissue, however, progesterone signaling is more complex, and its effects depend on the hormonal environment and receptor characteristics.
Testosterone and Hormone Sensitive Cancers
In women, elevated insulin levels may stimulate ovarian androgen production while reduced SHBG increases the amount of biologically available testosterone. Some of this testosterone can subsequently be converted into estrogen through aromatase activity in adipose tissue, creating another connection between insulin resistance and estrogen exposure. In men, obesity and insulin resistance are more commonly associated with lower total testosterone levels, although androgen signaling remains central to the biology of many prostate cancers. These differences highlight why insulin resistance does not affect all sex hormones in the same way and why metabolic health should be evaluated within each patient's individual clinical context.
The Importance of a Low Glycemic Diet
A low glycemic diet emphasizes carbohydrate containing foods that produce a slower and more gradual increase in blood glucose following consumption. These foods are often rich in dietary fiber and include legumes, whole fruits, non-starchy vegetables, and minimally processed whole grains. By emphasizing these foods and limiting refined carbohydrates and added sugars, individuals may improve postprandial glucose regulation and support healthier insulin sensitivity. The overall nutritional pattern is more important than simply avoiding individual foods with a high glycemic index.
Dietary fiber is particularly valuable because certain types slow carbohydrate digestion and absorption, helping moderate the rise in blood glucose following meals. Fiber also supports the intestinal microbiome by providing nutrients for beneficial bacteria that produce short chain fatty acids, including butyrate, acetate, and propionate. These compounds participate in intestinal barrier function, immune regulation, and metabolic signaling, areas that have received increasing attention in cancer research. As I have discussed in previous articles, maintaining a healthy gut microbiome is an important consideration within a comprehensive approach to integrative oncology.
A low glycemic dietary pattern should not be confused with eliminating carbohydrates or following an extremely restrictive diet. Whole fruits, legumes, and minimally processed grains provide important vitamins, minerals, fiber, and phytonutrients that support overall health. Even foods with a relatively high glycemic index can contribute valuable nutrients, depending on portion size and the composition of the overall meal. The goal is to emphasize nutrient dense foods while maintaining appropriate calorie and protein intake.
For a practical guide to choosing lower glycemic foods, including a chart of common foods and their glycemic index values, read my companion article, Understanding Glycemic Index & Glycemic Load: A Guide to Choosing Healthier Foods.
Special Considerations During Cancer Treatment
For patients undergoing active cancer treatment, nutritional recommendations must always be individualized according to treatment related symptoms, nutritional status, and overall health. Chemotherapy, immunotherapy, radiation, and surgery can contribute to nausea, vomiting, diarrhea, appetite changes, and unintended weight loss. In these situations, maintaining adequate calorie and protein intake may be more important than strictly following a low glycemic dietary pattern. Patients experiencing malnutrition, significant weight loss, or cancer related muscle wasting should avoid restrictive dietary programs without guidance from their oncology care team.
Certain cancer treatments and supportive medications can also affect blood glucose regulation. Corticosteroids, commonly administered during chemotherapy, may temporarily increase blood glucose levels, particularly in individuals with diabetes or insulin resistance. Some patients may require closer glucose monitoring, medication adjustments, or individualized medical nutrition therapy during treatment. An appropriate integrative oncology nutrition plan should account for these factors while supporting treatment tolerance, recovery, and quality of life.
The Importance of Metabolic Health in Cancer Survivorship
For individuals who have completed cancer treatment, improving metabolic health can be an important component of long-term survivorship care. Maintaining a healthy body composition, reducing excess visceral adiposity when appropriate, preserving muscle mass, and improving insulin sensitivity may help reduce the risk of several chronic diseases. These strategies are particularly relevant for survivors with insulin resistance, type 2 diabetes, metabolic syndrome, or a history of hormone sensitive cancers. However, it is important to distinguish established metabolic health benefits from claims that a low glycemic diet directly prevents cancer recurrence.
Physical activity also plays an important role because skeletal muscle is a major site of glucose utilization. Regular aerobic activity and appropriate resistance exercise can improve insulin sensitivity, support muscle maintenance, and contribute to healthier body composition. Combining these activities with a balanced dietary pattern rich in vegetables, fruits, legumes, whole grains, and quality protein sources offers a practical approach to long term metabolic health. These recommendations should be adapted to each survivor's physical capabilities, treatment history, and nutritional needs.
Conclusion: Supporting Metabolic Health Through Nutrition
The relationship between blood glucose, insulin, adipose tissue, hormone regulation, and cancer provides important insight into the role of metabolic health in cancer prevention and survivorship. Chronically elevated insulin levels, excess visceral adiposity, inflammation, and changes in sex hormone availability are among the biological mechanisms associated with increased risk for certain cancers. A low glycemic dietary pattern can be a practical strategy for supporting healthy glucose regulation and insulin sensitivity while providing essential nutrients for overall health. Although nutrition cannot replace conventional cancer treatment, it remains an important component of comprehensive integrative oncology care.
Throughout my clinical practice, I have emphasized that nutritional recommendations should be individualized according to each patient's diagnosis, treatment plan, metabolic health, and nutritional needs. The objective is not to eliminate carbohydrates or attempt to starve cancer cells of glucose, but rather to support a healthier metabolic environment through sustainable dietary and lifestyle choices. For individuals undergoing treatment or navigating survivorship, these choices can contribute to overall wellness and long-term health.
To learn more about integrative approaches to cancer care, explore the educational resources available here at Integrative Oncology Specialist.




